Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (481)

2024

  1. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

2023

  1. AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability

    Brain, Behavior, and Immunity, Vol. 108, pp. 255-268

  2. Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

    Multiple Sclerosis and Related Disorders, Vol. 75

  3. Association between periodontitis and peripheral markers of innate immunity activation and inflammation

    Journal of Periodontology, Vol. 94, Núm. 1, pp. 11-19

  4. Best practices in phase III clinical trials on DMTs for multiple sclerosis: A systematic analysis and appraisal of published trials

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 95, Núm. 4, pp. 333-341

  5. Beyond hyperglycemia: glycaemic variability as a prognostic factor after acute ischemic stroke

    Neurologia, Vol. 38, Núm. 3, pp. 150-158

  6. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 861-871

  7. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

    Neurologia, Vol. 38, Núm. 5, pp. 326-333

  8. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  9. Epidemiología de la miastenia grave en la península ibérica y Latinoamérica

    Revista de neurologia, Vol. 76, Núm. 2, pp. 59-68

  10. Estimulación cerebral profunda subtalámica en un caso de enfermedad de Parkinson idiopática y esquizofrenia

    Revista de neurologia, Vol. 77, Núm. 7, pp. 167-170

  11. Exploring the Spectrum of RHOBTB2 Variants Associated with Developmental Encephalopathy 64: A Case Series and Literature Review

    Movement Disorders Clinical Practice, Vol. 10, Núm. 11, pp. 1671-1679

  12. Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review

    International journal of molecular sciences, Vol. 24, Núm. 18

  13. How Can Radiomics Help the Clinical Management of Patients with Acute Ischemic Stroke?

    Applied Sciences (Switzerland), Vol. 13, Núm. 18

  14. Influence of Temperature Chronobiology on Stroke Outcome

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  15. La señal de la cruz: un automatismo muy poco frecuente en la epilepsia del lóbulo temporal. Descripción de dos casos

    Revista de neurologia, Vol. 77, Núm. 4, pp. 105-108

  16. Liquid Chromatography Fingerprint Analysis of Released Compounds in Plasma Samples of Stroke Patients after Thrombolytic Treatment

    Separations, Vol. 10, Núm. 1

  17. MiRNA Differences Related to Treatment-Resistant Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  18. Myasthenia gravis. Update on diagnosis and therapy

    Medicina Clinica, Vol. 161, Núm. 3, pp. 119-127

  19. Neurotological emergencies: a narrative review

    European Archives of Oto-Rhino-Laryngology, Vol. 280, Núm. 11, pp. 4759-4774